GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Cyclically Adjusted PB Ratio

Bristol-Myers Squibb Co (BSP:BMYB34) Cyclically Adjusted PB Ratio : 3.01 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Bristol-Myers Squibb Co's current share price is R$213.69. Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was R$70.92. Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio for today is 3.01.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:BMYB34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.8   Med: 5.83   Max: 8.86
Current: 2.8

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted PB Ratio was 8.86. The lowest was 2.80. And the median was 5.83.

BSP:BMYB34's Cyclically Adjusted PB Ratio is ranked worse than
64.31% of 692 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs BSP:BMYB34: 2.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted book value per share data for the three months ended in Mar. 2024 was R$40.512. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$70.92 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.35 5.50 4.95 5.23 3.52

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.91 4.45 3.99 3.52 3.68

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio falls into.



Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=213.69/70.92
=3.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=40.512/131.7762*131.7762
=40.512

Current CPI (Mar. 2024) = 131.7762.

Bristol-Myers Squibb Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 20.671 100.560 27.088
201409 21.343 100.428 28.005
201412 23.737 99.070 31.573
201503 29.296 99.621 38.752
201506 28.221 100.684 36.936
201509 35.279 100.392 46.308
201512 33.331 99.792 44.014
201603 31.869 100.470 41.799
201606 30.565 101.688 39.609
201609 30.392 101.861 39.318
201612 32.607 101.863 42.183
201703 27.367 102.862 35.060
201706 29.537 103.349 37.661
201709 28.293 104.136 35.803
201712 23.807 104.011 30.162
201803 25.664 105.290 32.120
201806 28.463 106.317 35.279
201809 34.336 106.507 42.482
201812 33.552 105.998 41.712
201903 35.732 107.251 43.903
201906 37.829 108.070 46.127
201909 44.622 108.329 54.280
201912 95.056 108.420 115.533
202003 107.781 108.902 130.420
202006 113.011 108.767 136.918
202009 119.860 109.815 143.830
202012 87.610 109.897 105.052
202103 94.905 111.754 111.908
202106 83.294 114.631 95.752
202109 88.504 115.734 100.772
202112 94.413 117.630 105.768
202203 73.814 121.301 80.188
202206 77.075 125.017 81.242
202209 80.574 125.227 84.788
202212 78.519 125.222 82.629
202303 78.933 127.348 81.678
202306 74.288 128.729 76.047
202309 70.409 129.860 71.448
202312 71.351 129.419 72.650
202403 40.512 131.776 40.512

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BSP:BMYB34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (BSP:BMYB34) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (BSP:BMYB34) Headlines

No Headlines